Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDS-Switch
NCT03492463Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2018
- Primary completion
- May 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nicotine patch in nicotine dependence (4 arms), sponsored by Duke University. Primary endpoint: Expired Air Carbon Monoxide at 8 weeks. Started Aug 2018; status: completed.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03492463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03492463.